Log in
Enquire now
‌

US Patent 9884876 Anti-viral compounds, pharmaceutical compositions, and methods of use thereof

Patent 9884876 was granted and assigned to Kineta, Inc. on February, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Kineta, Inc.
0
Current Assignee
‌
Kineta, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
98848760
Patent Inventor Names
Kristin M. Bedard0
Shawn P. Iadonato0
Ikenna Madu0
Kerry W. Fowler0
Shari Kaiser0
Date of Patent
February 6, 2018
0
Patent Application Number
153080580
Date Filed
May 8, 2015
0
Patent Citations Received
‌
US Patent 11851429 AMPK activators
0
Patent Primary Examiner
‌
Alicia L Otton
0
Patent abstract

Disclosed herein are compounds, pharmaceutical compositions, and related methods for the treatment of viral infection, including RNA viral infection in subjects. The compounds, pharmaceutical compositions, and methods can modulate the innate immune antiviral response in vertebrate cells, including activating the RIG-I pathway.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9884876 Anti-viral compounds, pharmaceutical compositions, and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.